| 0 |
Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor [EPC] |
1 |
0.0004 |
| 1 |
Iron Chelator [EPC] |
2 |
0.0001 |
| 2 |
Orexin Receptor Antagonist [EPC] |
1 |
0.0001 |
| 3 |
Human Immunoglobulin G [EPC] |
1 |
0.0000 |
| 4 |
Prostacyclin Receptor Agonist [EPC] |
1 |
0.0000 |
| 5 |
Histamine-1 Receptor Antagonist [EPC] |
3 |
0.0000 |
| 6 |
Soluble Guanylate Cyclase Stimulator [EPC] |
1 |
0.0000 |
| 7 |
Tetracycline-class Drug [EPC] |
2 |
0.0000 |
| 8 |
Serotonin-3 Receptor Antagonist [EPC] |
3 |
0.0000 |
| 9 |
Muscle Relaxant [EPC] |
1 |
0.0000 |
| 10 |
Erythropoiesis-stimulating Agent [EPC] |
1 |
0.0000 |
| 11 |
Factor Xa Inhibitor [EPC] |
5 |
0.0000 |
| 12 |
Histamine-2 Receptor Antagonist [EPC] |
2 |
0.0000 |
| 13 |
Phosphodiesterase 5 Inhibitor [EPC] |
2 |
0.0000 |
| 14 |
Prostacycline Vasodilator [EPC] |
2 |
0.0000 |
| 15 |
Vitamin D [EPC] |
4 |
0.0000 |
| 16 |
Janus Kinase Inhibitor [EPC] |
2 |
0.0000 |
| 17 |
Vitamin B12 [EPC] |
4 |
0.0000 |
| 18 |
Microtubule Inhibitor [EPC] |
2 |
0.0000 |
| 19 |
Platinum-based Drug [EPC] |
3 |
0.0000 |
| 20 |
Endothelin Receptor Antagonist [EPC] |
2 |
0.0000 |
| 21 |
Vitamin C [EPC] |
4 |
0.0000 |
| 22 |
Sodium-Glucose Cotransporter 2 Inhibitor [EPC] |
1 |
0.0000 |
| 23 |
Insulin Analog [EPC] |
4 |
0.0000 |
| 24 |
Alkylating Drug [EPC] |
2 |
0.0000 |
| 25 |
alpha-Adrenergic Blocker [EPC] |
1 |
0.0000 |
| 26 |
Aldosterone Antagonist [EPC] |
1 |
0.0000 |
| 27 |
CD20-directed Cytolytic Antibody [EPC] |
2 |
0.0000 |
| 28 |
Corticosteroid [EPC] |
6 |
0.0000 |
| 29 |
Folate Analog Metabolic Inhibitor [EPC] |
2 |
0.0000 |
| 30 |
Loop Diuretic [EPC] |
2 |
0.0000 |
| 31 |
Opioid Agonist [EPC] |
1 |
0.0000 |
| 32 |
Proton Pump Inhibitor [EPC] |
2 |
0.0000 |
| 33 |
beta-Adrenergic Blocker [EPC] |
1 |
0.0000 |
| 34 |
Angiotensin 2 Receptor Blocker [EPC] |
1 |
0.0000 |
| 35 |
Nonsteroidal Anti-inflammatory Drug [EPC] |
4 |
0.0000 |
| 36 |
Benzodiazepine [EPC] |
2 |
0.0000 |
| 37 |
GLP-1 Receptor Agonist [EPC] |
1 |
0.0000 |